The Cluster4Future PROXIDRUGS and the innovation platform Futury GmbH have formed a strategic partnership with the aim of setting new...

On 8th of May 2025, the House of Pharma & Healthcare organised an exchange on the potential of pharmaceutical research at the University...

A new publication in the Journal of Medicinal Chemistry the PROXIDRUGS project leader Felix Hausch and his team from TU Darmstadt,...

On 22 April, the PROXIDRUGS Cluster4Future together with its partner House of Pharma & Healthcare hosted a public event on the Niederrad...

In their publication in Nature Chemical Biology PROXIDRUGS researchers and collaborating universities have discovered a way to prevent...

Since the beginning of this year, 22 partners from academic and industrial research are working collaboratively together in the 2nd...

The 4th Frankfurt Conference on Quality Control in Life Processes welcomed more than 300 speakers and attendees from all over the world....

A new computational drug design challenge is being launched from our PROXIDRUGS partner Merck KGaA: the Proximity-Inducing Drugs...

Targeted protein degradation (TPD) is an emerging therapeutic strategy that hijacks the cellular recycling machinery to degrade and...

On November 18th and 19th present and new industry and academic partners came together for the annual PROXIDRUGS retreat to discuss...